Evaluation of the effect of food on the pharmacokinetics of avitriptan

被引:0
|
作者
Marathe, PH
Greene, DS
Kollia, GD
Barbhaiya, RH
机构
[1] Bristol Myers Squibb Co, Pharmaceut Res Inst, Dept Metab & Pharmacokinet, Princeton, NJ 08543 USA
[2] Bristol Myers Squibb Co, Pharmaceut Res Inst, Biostat & Data Management, Princeton, NJ 08543 USA
关键词
avitriptan; food effect; bioavailability;
D O I
10.1002/(SICI)1099-081X(199809)19:6<381::AID-BDD118>3.3.CO;2-A
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Bioavailability of avitriptan was found to decrease significantly when administered 5 min after a standard high fat meal. The studies described herein were carried out to gain insight into the mechanism of this food effect. A series of studies were conducted in humans to assess the effect of timing of meal, type of meal, gastric pH, change in the formulation and dose on the bioavailability of avitriptan. Avitriptan was administered as a 50 mg capsule under fasted condition and at 30 min, 1, 2 and 4 h after a standard high fat meal. The reduction in avitriptan bioavailability persisted even at 4 h post high fat meal, although as the time interval between the meal and dose increased, the effect of meal tended to decrease. Bioavailability of avitriptan also decreased significantly when the drug was administered after a high protein and a high carbohydrate meal. Elevation in gastric pH caused by food was not found to be responsible for the food-related decrease in bioavailability of avitriptan since ranitidine pretreatment did not lead to a decrease in bioavailability. When administered as a 50 mg C-14-labeled solution after a standard high fat meal, bioavailability of avitriptan decreased although the decrease was less compared with that observed for a capsule dosage form. Plasma concentrations and cumulative urinary excretion of total radioactivity also decreased in the fed condition, indicating the absorption of avitriptan was affected. The decrease in avitriptan AUC was somewhat more pronounced than the decrease in the exposure to the total radioactivity suggesting a food-related increase in the first-pass metabolism of avitriptan. Effect of the standard high fat meal on avitriptan administered as a 150 mg capsule was similar to that observed at the 50 mg dose. Overall, the results indicate that bioavailability of avitriptan is significantly reduced irrespective of the type of meal, dose and dosage form and the effect persists for as long as 4 h post meal. Thus, it appears that avitriptan absorption and bioavailability are highly sensitive to presence of food in the stomach and any food-related changes in gastric emptying time and gastrointestinal motility. (C) 1998 John Wiley & Sons, Ltd.
引用
收藏
页码:381 / 394
页数:14
相关论文
共 50 条
  • [21] Effect of autoinduction and food on the pharmacokinetics of furmonertinib and its active metabolite characterized by a population pharmacokinetic model
    Zou, Hui-xi
    Zhang, Yu-feng
    Zhong, Da-fang
    Jiang, Yong
    Liu, Fei
    Zhao, Qian-yu
    Zuo, Zhong
    Zhang, Yi-fan
    Yan, Xiao-yu
    ACTA PHARMACOLOGICA SINICA, 2022, 43 (07) : 1865 - 1874
  • [22] Effect of food on the pharmacokinetics of multiple-dose oral voriconazole
    Purkins, L
    Wood, N
    Kleinermans, D
    Greenhalgh, K
    Nichols, D
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2003, 56 : 17 - 23
  • [23] Effect of Food on the Pharmacokinetics and Pharmacodynamics of a Single Oral Dose of Tegoprazan
    Han, Sungpil
    Choi, Hee Youn
    Kim, Yo Han
    Nam, Ji Yeon
    Kim, Bongtae
    Song, Geun Seog
    Lim, Hyeong-Seok
    Bae, Kyun-Seop
    CLINICAL THERAPEUTICS, 2021, 43 (08) : 1371 - 1380
  • [24] HYDRALAZINE PHARMACOKINETICS AND INTERACTION WITH FOOD - AN EVALUATION OF THE DOG AS AN ANIMAL-MODEL
    SEMPLE, HA
    TAM, YK
    COUTTS, RT
    PHARMACEUTICAL RESEARCH, 1990, 7 (03) : 274 - 279
  • [25] The absolute bioavailability and effect of food on the pharmacokinetics of zolmitriptan in healthy volunteers
    Seaber, EJ
    Peck, RW
    Smith, DA
    Allanson, J
    Hefting, NR
    van Lier, JJ
    Sollie, FAE
    Wemer, J
    Jonkman, JHG
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1998, 46 (05) : 433 - 439
  • [26] A phase 1 study to evaluate effect of food on veliparib pharmacokinetics and relative bioavailability in subjects with solid tumors
    Mostafa, Nael M.
    Chiu, Yi-Lin
    Rosen, Lee S.
    Bessudo, Alberto
    Kovacs, Xenia
    Giranda, Vincent L.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2014, 74 (03) : 583 - 591
  • [27] A phase 1 study to evaluate effect of food on veliparib pharmacokinetics and relative bioavailability in subjects with solid tumors
    Nael M. Mostafa
    Yi-Lin Chiu
    Lee S. Rosen
    Alberto Bessudo
    Xenia Kovacs
    Vincent L. Giranda
    Cancer Chemotherapy and Pharmacology, 2014, 74 : 583 - 591
  • [28] Effect of Food Intake or Coadministration With an Acid-Reducing Agent on Lenacapavir Pharmacokinetics Following Oral Administration
    Singh, Renu
    Shelton, Mark
    Olson, Isabel
    Ling, John
    West, Steve
    Levy, Jeffrey A.
    Rhee, Martin S.
    Girish, Sandhya
    Palaparthy, Ramesh
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2025, : 324 - 332
  • [29] Population pharmacokinetics of blonanserin in Chinese healthy volunteers and the effect of the food intake
    Wen, Yu-Guan
    Shang, De-Wei
    Xie, He-Zhi
    Wang, Xi-Pei
    Ni, Xiao-Jia
    Zhang, Ming
    Lu, Wei
    Qiu, Chang
    Liu, Xia
    Li, Fang-Fang
    Li, Xuan
    Luo, Fu-Tian
    HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2013, 28 (02) : 134 - 141
  • [30] Effect of itraconazole, food, and ethnic origin on the pharmacokinetics of ivosidenib in healthy subjects
    Dai, David
    Yang, Hua
    Nabhan, Salah
    Liu, Hua
    Hickman, Denice
    Liu, Guowen
    Zacher, Jeffrey
    Vutikullird, Apinya
    Prakash, Chandra
    Agresta, Samuel
    Bowden, Chris
    Fan, Bin
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2019, 75 (08) : 1099 - 1108